LEDERLE's $65 MIL. IN COMMODITY Rx BUSINESS IN U.S. IS SECOND BEHIND ROBINS AMONG RESEARCH FIRMS: LEDERLE HAS BROAD LINE, BACKWARDS INTEGRATION

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".